Interaction of nitromethane with reduced hepatic microsomal cytochrome P-450.
D000814:Aniline Compounds / Q000378:metabolism; D000818:Animals; D002248:Carbon Monoxide / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004227:Dithionite / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D009022:Morphine Derivatives / Q000378:metabolism; D009574:Nitro Compounds / Q000378:metabolism* / Q000494:pharmacology; D010084:Oxidation-Reduction; D010634:Phenobarbital / Q000494:pharmacology; D011817:Rabbits; D013053:Spectrophotometry
D000814:Aniline Compounds; D009022:Morphine Derivatives; D009574:Nitro Compounds; D004227:Dithionite; D008748:Methylcholanthrene; D002248:Carbon Monoxide; D003577:Cytochrome P-450 Enzyme System; D010634:Phenobarbital